Prostate Cancer News & Features

Inherited high-risk mutation for prostate cancer identified

January 26, 2012

Researchers have discovered a rare but recurrent mutation that increases the risk of hereditary prostate cancer by up to 20 times.
 

Imaging May Spare Nerves in Prostate Cancer Surgery

January 25, 2012

Preoperative MRI led to a change in surgical plan in 27 percent of robot-assisted prostatectomies.
 

Music-playing headphones keep men calm during prostate biopsy

January 25, 2012

Providing men with noise-canceling headphones that play music may be a simple intervention for reducing their anxiety and pain perception while they are undergoing a prostate biopsy.
 

Proton therapy effective against prostate cancer

January 19, 2012

Two studies published in International Journal of Radiation Oncology*Biology*Physics indicate that proton therapy is a useful treatment for prostate cancer.
 

ACS annual report says cancer mortality is decreasing

Delicia Honen Yard January 10, 2012

Cancer incidence rates in men declined by 0.6% per year and remained stable in women and cancer mortality fell by 1.8% per year for men and by 1.6% per year for women between 2004 and 2008.
 

Cutaneous melanoma begets cutaneous melanoma

Delicia Honen Yard January 06, 2012

Continued skin surveillance is important for survivors of cutaneous melanoma (CM), indicate findings showing that this is the most common second primary cancer among persons with a first CM.
 

Cancer-Related Mortality Continues to Decrease

January 04, 2012

Overall cancer rates have decreased for men and remained stable for women, but mortality from cancer has declined for both sexes, according to a report from the American Cancer Society.
 

Experts have conflicting views on CV risk in prostate cancer therapy

Delicia Honen Yard December 20, 2011

A meta-analysis provides reassurance that androgen deprivation therapy is not associated with an increased risk of cardiovascular deaths, but other specialists warn against ignoring this risk.
 

Prostate Cancer: What You Should Know About Screening and Diagnosis

December 19, 2011

Prostate cancer screening is important in the early detection of prostate cancer because many patients do not have symptoms. This guide reviews current screening tests, recommendations, and risk factors.
 

Fish oil and a low-fat diet slowed growth of PCa cells

December 16, 2011

Lowering dietary fat and decreasing the ratio of omega-6 to omega-3 PUFAs reduces the risk of prostate cancer development and progression in men, a recent study in Cancer Prevention Research found.
 

Prostate Cancer News from Renal & Urology News

Prostate Cancer

Imaging May Spare Nerves in Prostate Cancer Surgery

January 25, 2012

Preoperative MRI led to a change in surgical plan in 27% of robot-assisted prostatectomies
 
Prostate Cancer

Dutasteride Delays Progression of Low-Risk Prostate Cancer

January 25, 2012

For men with low-risk prostate cancer who undergo active surveillance, treatment with dutasteride delays the time to cancer progression, a study found.
 
Prostate Cancer

Prostate Biopsies Rarely Lead to Hospitalization

January 12, 2012

Hospital admissions related to a prostate needle biopsy (PNB) are on the increase, but they occur in less than 1% of men who undergo PNB and are not associated with excess mortality, researchers concluded in an online report in European Urology.
 
Prostate Cancer

Gene Variant Linked to Hereditary Prostate Cancer

January 11, 2012

Mutation more common in early-onset, familial cancers
 
Prostate Cancer

Minimally Invasive Surgery for Prostate Cancer Increasing, Offers Better Results

December 28, 2011

Use of minimally invasive radical prostatectomy (MIRP) for patients with prostate cancer (PCa) increased and the use of retropubic radical prostatectomy (RRP) decreased significantly from 2003 to 2007, a study found.
 

Prostate Cancer Clinical Trials

Clinical Trial: Impact of F-18-Fluorocholine PET/CT and MR Imaging/ Spectroscopy in the Management of Primary and Recurrent Prostate Cancer

Clinical Trial: MR Image Guided Therapy in Prostate Cancer

Clinical Trial: PROstaTE Cancer Treatment and Obesity in Zoladex-Astrazeneca Treated Patients

Clinical Trial: Efficacy and Safety Study of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance.

Clinical Trial: Studying Genes, Environment, and Prostate Cancer Risk in Patients With or Without Prostate Cancer and Their First-Degree Relatives

Free CE from mycme.com

Discussions on Emerging Concepts and Controversies in the Treatment of Patients with Advanced Non-Small Cell Lung Cancer

2.00 / AMA PRA Category 1 Credit(s)TM
This program reviews developments in maintenance therapy and evaluates the relevance of tumor histology and biomarker analysis for the management of NSCLC patients.
 

Cancer care is expensive.
CancerCare can help.


Connect Booklets
FEBRUARY 3 - 4
• 2012 Highlights of ASH in North America
New York, New York
• 2012 Highlights of ASH in North America
San Francisco, California
MARCH 3 - 4
• 2012 Highlights of ASH in Asia
Singapore, Singapore
MAY 3 - 6
• 37th Annual ONS Congress
New Orleans, Louisiana
 Subscribe to the RSS for this page  [view all our RSS feeds here]

Web Exclusives

Psychosocial approach useful in managing cancer pain

February 03, 2012

Psychosocial interventions, including skills instruction and education, can help reduce pain in persons with cancer, confirm the results of a recent meta-analysis.
 

Experimental agent slows progression of colorectal cancer

February 02, 2012

The investigational drug regorafenib conferred a statistically significant survival benefit in patients with metastatic colorectal cancer in whom no standard therapy was effective.
 

In HER2 breast cancer, lapatinib works better with trastuzumab than without

February 01, 2012

Lapatinib is not as effective as trastuzumab against (HER2)-positive breast cancer, but combining the two nearly doubles the effectiveness seen with either one alone.
 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions